Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016

Mengyin WU; Chunxiao WU; Yi PANG; Chunfang WANG; Kai GU; Yangming GONG; Pingping BAO; Liang SHI; Jianming DOU; Yongmei XIANG; Yan SHI

doi:10.19401/j.cnki.1007-3639.2022.02.001

您当前的位置：

首页 >

文章列表页 >

Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016

更新时间：2025-12-31

- Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016
- China Oncology Vol. 32, Issue 2, Pages: 97-105(2022)
- 作者机构：
  
  1. 上海市疾病预防控制中心,慢性非传染病与伤害防治所,上海200336
  2. 上海市疾病预防控制中心,疾病预防控制信息所,上海200336
- 作者简介：
  
  SHI Yan E-mail: shiyan@scdc.sh.cn
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.02.001
  CLC： R735.9
- Received：05 November 2021，
  
  Published：28 February 2022
- 稿件说明：
移动端阅览
Mengyin WU, Chunxiao WU, Yi PANG, et al. Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016[J]. China Oncology, 2022, 32(2): 97-105.
DOI：

Mengyin WU, Chunxiao WU, Yi PANG, et al. Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016[J]. China Oncology, 2022, 32(2): 97-105. DOI： 10.19401/j.cnki.1007-3639.2022.02.001.

摘要

背景与目的：

上海市疾病预防控制中心每年更新上海市胰腺癌发病和死亡及其趋势的统计资料。胰腺癌是常见的消化道恶性肿瘤之一

由于其起病隐匿

预后极差

给患者及其家庭、社会带来了极大的疾病负担。分析2016年上海市胰腺癌发病和死亡情况及2002—2016年流行趋势

以期了解上海市胰腺癌的流行现状及变化趋势

为胰腺癌的防治和进一步研究提供依据。

方法

2002—2016年上海市胰腺癌发病和死亡资料来源于上海市疾病预防控制中心人群基础肿瘤登记管理系统和死因登记系统。所有胰腺癌资料以病理学诊断（morphological verification

MV）和非病理学诊断作为最高诊断依据。根据发病或死亡年份、性别、年龄组统计各亚组人群发病和死亡数、粗率、构成比、年龄别率及累积率;使用Segi’s 1960世界标准人口构成计算年龄标准化发病率、年龄标准化死亡率及相应的35~64岁截缩率;使用

检验比较不同亚组年龄别率的差异;使用加权卡方检验法比较不同亚组标化率的差异。逐年率值的时间趋势分析通过Joinpoint软件进行计算和比较;使用年度变化百分比描述整个研究期间上海市胰腺癌发病及死亡的变化趋势;使用Joinpoint回归模型比较不同时期发病率及死亡率的变化趋势。

结果

2016年上海市胰腺癌新发病例的MV比例为41.25%

去除死亡认证病例的比例为0.68%

死亡发病数比为0.87。2016年上海市胰腺癌新发病例数和死亡人数分别为2 943例和2 554人

粗发病率为20.32/10万

标化发病率为7.28/10万

胰腺癌新发病例占所有恶性肿瘤的3.95%

居恶性肿瘤发病谱的第7位

35~64岁截缩发病率为9.53/10万;0~64岁、0~74岁及0~84岁累积发病率分别为0.34%、0.81%和1.76%;粗死亡率为17.64/10万

标化死亡率为6.01/10万

胰腺癌死亡病例占所有恶性肿瘤死亡病例的6.90%

居恶性肿瘤死亡谱的第5位

35~64岁截缩死亡率为7.16/10万;0~64岁、0~74岁及0~84岁累积死亡率分别为0.26%、0.64%和1.57%。男性的标化发病率和标化死亡率均显著高于女性。2016年上海市胰腺癌的年龄别发病和死亡的数量和率值均随年龄增加呈现上升趋势

年龄别发病率和死亡率在85岁以上组人群均达到了峰值

分别为108.66/10万和106.97/10万。2002—20

16年上海市胰腺癌新发病例数和死亡人数呈现逐渐增加的趋势

其中胰腺癌的新发病例数由2002年的1 510例上升至2016年的2 943例;死亡人数由2002年的1 458人上升至2016年的2 554人。Joinpoint分析表明

2002—2016年上海市胰腺癌的标化发病率呈现明显的上升趋势

年均增速为0.89%[年度变化百分比（annual percent change

APC）=0.89

=5.69

0.001

]

而标化死亡率的增加差异无统计学意义。

结论

2002—2016年上海市胰腺癌发病率呈上升趋势

标化死亡率则保持稳定。由于目前尚无有效的筛查手段

因此基于人群的胰腺癌发病和死亡现况及趋势研究对于胰腺癌防治有重要的公共卫生意义。

Abstract

Background and purpose:

The Shanghai Municipal Center for Disease Control and Prevention provides annual updates on pancreatic cancer occurrence and trends in Shanghai. Pancreatic cancer

which has increased the disease burden to the society and patients with their families due to the lack of early symptoms and poor prognosis

remains one of the most common gastrointestinal tumors. This study aimed to analyze the current epidemic status of pancreatic cancer in Shanghai in 2016 and the prevalence trend from 2002 to 2016

and to provide a basis for the prevention and treatment of pancreatic cancer and further research.

Methods:

Data on pancreatic cancer in Shanghai from 2002 to 2016 were obtained through Shanghai Municipal Center for Disease Control and Prevention Population-based Cancer Registry and Vital Statistics System. In all cases of pancreatic cancer

morphological verification (MV) and non-morphological verification were taken as the highest basis for diagnosis. The number of cases and deaths

crude rates

composition ratios

age-specific rates and cumulative rates were counted according to the year of incidence or death

sex and age groups. Segi’s 1960 world standard population was used to calculate age-standardized rates of incidence and mortality and corresponding truncated age-standardized rate (35-64 years) of pancreatic cancer.

-test and Cochran test were used to compare the differences of age-specific rates and age-standardized rates among different subgroups

respectively

. Temporal trend analyses were conducted by Joinpoint software

and annual percent changes (APCs) were used to describe the trends.

Results:

In 2016

the MV proportion of new cases of pancreatic cancer in Shanghai was 41.25%

the proportion of cases with death certification only was 0.68%

and the ratio of death to incidence was 0.87. The number of new cases and deaths of pancreatic cancer in Shanghai in 2016 was 2 943 and 2 554

respectively. The crude incidence of pancreatic cancer in Shanghai in 2016 was 20.32/100 000

with an age-standardized incidence of 7.28/100 000. New cases of pancreatic cancer accounted for 3.95% of all malignant tumors

ranking 7

in the incidence spectrum of malignant tumors. The truncated age-standardized incidence (35-64 years) was 9.53/100 000

and the cumulative incidences for 0-64 years

0-74 years and 0-84 years were 0.34%

0.81% and 1.76%

respectively. The crude mortality of pancreatic cancer in Shanghai in 2016 was 17.64/100 000

with an age-standardized mortality of 6.01/100 000. Deaths of pancreatic cancer accounted for 6.90% of all malignant tumor deaths

ranking 5

in the mortality spectrum of malignant tumors. The truncated age-standardized mortality (35-64 years) was 7.16/100 000

and the cumulative mortalities for 0-64 years

0-74 years and 0-84 years were 0.26%

0.64% and 1.57%

respectively. The age-standardized incidence and mortality were significantly higher in men than in women. The age-specific new cases

deaths and rates of pancreatic cancer in Shanghai in 2016 showed an upward trend with increasing age

and the age-specific incidence and mortality peaked at 108.66/100 000 and 106.97/100 000

respectively

among people aged 85 and over. From 2002 to 2016

both the number of new cases and deaths of pancreatic cancer in Shanghai showed a gradual increase trend

of which the number of new cases of pancreatic cancer increased from 1 510 in 2002 to 2 943 in 2016

and the number of deaths increased from 1 4

58 in 2002 to 2 554 in 2016. Joinpoint analyses showed a significant upward trend in the standardized incidence of pancreatic cancer in Shanghai from 2002 to 2016

with an average annual increase of 0.89% (APC=0.89

=5.69

0.001)

while the increase in standardized mortality was not statistically significant.

Conclusions:

The incidence of pancreatic cancer in Shanghai from 2002 to 2016 showed an upward trend

while the mortality showed a fluctuating trend. Since there is no effective screening tool

a population-based study on the current epidemic status and trend of pancreatic cancer is of great significance for pancreatic cancer prevention and treatment.

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .

ZHANG S W , SUN K X , ZHENG R S , et al . Cancer incidence and mortality in China, 2015 [J ] . J Natl Cancer Cent , 2021 , 1 ( 1 ): 2 - 11 .

徐晓慧 , 曾新颖 , 王黎君 , 等 . 1990 年与2017年中国胰腺癌疾病负担分析 [J ] . 中华流行病学杂志 , 2019 ( 9 ): 1084 - 1088 .

XU X H , ZENG X Y , WANG L J , et al . The disease burden of pancreatic cancer in China in 1990 and 2017 [J ] . Chin J Epidemiol , 2019 ( 9 ): 1084 - 1088 .

国家癌症中心 . 中国肿瘤登记工作指导手册-2016 [M ] . 北京 : 人民卫生出版社 , 2016 : 59 ~ 75 .

National Cancer Center . China cancer registration instruction manual-2016 [M ] . Beijing : People’s Health Publishing House , 2016 : 59 ~ 75 .

PARKIN D , CHEN V , FERLAY J . Comparability and quality control in cancer registration. IARC technical report No.19 [M ] . Lyon: IARC. 1994 .

吴春晓 , 龚杨明 , 顾凯 , 等 . 2016年上海市结肠直肠癌发病和死亡情况与2002—2016年间的变化趋势分析 [J ] . 外科理论与实践 , 2021 , 26 ( 4 ): 325 - 335 .

WU C X , GONG Y M , GU K , et al . Colorectal cancer incidence and mortality in Shanghai 2016 and trend analysis 2002—2016 [J ] . J Surg Concepts Pract , 2021 , 26 ( 4 ): 325 - 335 .

GREENE F L , PAGE D L , FLEMING I D , et al . AJCC cancer staging manual (6th Edition) [J ] . Ann J Oncol , 2003 , 14 ( 2 ): 345 .

CHEN W Q , ZHENG R S , BAADE P D , et al . Cancer statistics in China, 2015 [J ] . CA Cancer J Clin , 2016 , 66 ( 2 ): 115 - 132 .

RAWLA P , SUNKARA T , GADUPUTI V . Epidemiology of pancreatic cancer: global trends, etiology and risk factors [J ] . World J Oncol , 2019 , 10 ( 1 ): 10 - 27 .

HUANG J J , LOK V , NGAI C H , et al . Worldwide burden of, risk factors for, and trends in pancreatic cancer [J ] . Gastroenterology , 2021 , 160 ( 3 ): 744 - 754 .

蔡洁 , 陈宏达 , 卢明 , 等 . 2005-2015年中国胰腺癌发病与死亡趋势分析 [J ] . 中华流行病学杂志 , 2021 , 42 ( 5 ): 794 - 800 .

CAI J , CHEN H D , LU M , et al . Trend analysis of incidence and mortality of pancreatic cancer in China in 2005-2015 [J ] . Chin J Epidemiol , 2021 , 42 ( 5 ): 794 - 800 .

HIDALGO M . Pancreatic cancer [J ] . N Engl J Med , 2010 , 362 ( 17 ): 1605 - 1617 .

BOSETTI C , BERTUCCIO P , NEGRI E , et al . Pancreatic cancer: overview of descriptive epidemiology [J ] . Mol Carcinog , 2012 , 51 ( 1 ): 3 - 13 .

PARKIN D M , BOYD L , WALKER L C . 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 [J ] . Br J Cancer , 2011 , 105 ( Suppl 2 ): S77 - S81 .

EZZATI M , HENLEY S J , LOPEZ A D , et al . Role of smoking in global and regional cancer epidemiology: current patterns and data needs [J ] . Int J Cancer , 2005 , 116 ( 6 ): 963 - 971 .

GENKINGER J M , SPIEGELMAN D , ANDERSON K E , et al . A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk [J ] . Int J Cancer , 2011 , 129 ( 7 ): 1708 - 1717 .

WEISS W , BENARDE M A . The temporal relation between cigarette smoking and pancreatic cancer [J ] . Am J Public Health , 1983 , 73 ( 12 ): 1403 - 1404 .

JAROSZ M , SEKUŁA W , RYCHLIK E . Influence of diet and tobacco smoking on pancreatic cancer incidence in Poland in 1960-2008 [J ] . Gastroenterol Res Pract , 2012 , 2012 : 682156 .

COKKINIDES V , ALBANO J , SAMUELS A , et al . American cancer society: cancer facts and figures [J ] . 2005

BEEGHLY-FADIEL A , LUU H N , DU L P , et al . Early onset pancreatic malignancies: clinical characteristics and survival associations [J ] . Int J Cancer , 2016 , 139 ( 10 ): 2169 - 2177 .

TINGSTEDT B , WEITKÄMPER C , ANDERSSON R . Early onset pancreatic cancer: a controlled trial [J ] . Ann Gastroenterol , 2011 , 24 ( 3 ): 206 - 212 .

RAIMONDI S , MAISONNEUVE P , LÖHR J M et al . Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors [J ] . Cancer Epidemiol Biomarkers Prev , 2007 , 16 ( 9 ): 1894 - 1897 .

MCWILLIAMS R R , MAISONNEUVE P , BAMLET W R , et al . Risk factors for early-onset and very-early-onset pancreatic adenocarcinoma: a pancreatic cancer case-control consortium (PanC4) analysis [J ] . Pancreas , 2016 , 45 ( 2 ): 311 - 316 .

姜勇 . 中国成人超重肥胖流行现状、变化趋势及健康危害研究 [D ] . 北京: 中国疾病预防控制中心 , 2013 .

JIANG Y . Study on the epidemic status, change trend and health hazards of overweight and obesity in Chinese adults [D ] . Beijing: China Center for Disease Control and Prevention , 2013 .

ZHENG Z X , ZHENG R S , HE Y T , et al . Risk factors for pancreatic cancer in China: a multicenter case-control study [J ] . J Epidemiol , 2016 , 26 ( 2 ): 64 - 70 .

BO X J , SHI J W , LIU R , et al . Using the risk factors of pancreatic cancer and their interactions in cancer screening: a case-control study in Shanghai, China [J ] . Ann Glob Health , 2019 , 85 ( 1 ): 103 .

上海糖尿病发病率高于全国平均年轻化趋势明显 [J ] . 糖尿病文摘 , 2014 , 12 : 6 - 7 .

The incidence rate of diabetes in Shanghai is higher than that in the whole country [J ] . Diabetes World , 2014 , 12 : 6 - 7 .

赵玉沛 . 胰腺癌诊断与治疗的现状与未来 [J ] . 中华肝胆外科杂志 , 2009 , 15 ( 5 ): 321 - 323 .

ZHAO Y P . Status quo and future of diagnosis and treatment of pancreatic cancer [J ] . Chin J Hepatobiliary Surg , 2009 , 15 ( 5 ): 321 - 323 .

MCGUIGAN A , KELLY P , TURKINGTON R C , et al . Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes [J ] . World J Gastroenterol , 2018 , 24 ( 43 ): 4846 - 4861 .

Views

1879

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016

Analysis of the current status of cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016

Analysis of incidence and mortality of colorectal cancer in China, 2015

Report of cancer epidemiology in Shanghai, 2015

Incidence and mortality of ovarian cancer among permanent residents in the Former Luwan District of Shanghai between 2002 and 2011

Related Author

Yi PANG

Chunxiao WU

Kai GU

Pingping BAO

Chunfang WANG

Liang SHI

Yangming GONG

Yongmei XIANG

Related Institution

Shanghai Municipal Center for Disease Control and Prevention

Division of Disease Control and Prevention Information, Shanghai Municipal Center for Disease Control and Prevention

上海市疾病预防控制中心，慢性非传染病与伤害防治所

上海市疾病预防控制中心，慢性非传染病与伤害防治所肿瘤防治科

上海市疾病预防控制中心

AI问答

⁰